MedPath

Prof. Dr. med. Mark U. Gerbershagen, MBA

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

5

Active:0
Completed:2

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Stability of Middle Molecule Clearance

Completed
Conditions
Continuous Hemodialysis
First Posted Date
2011-03-03
Last Posted Date
2014-12-19
Lead Sponsor
Klinik für Anästhesiologie
Target Recruit Count
15
Registration Number
NCT01308073
Locations
🇩🇪

Intensivstation ZOM1 Klinik für Anästhesiologie Universitätsklinikum Düsseldorf, Duesseldorf, Germany

Anticoagulation and Activation - Comparison in Continuous Renal Replacement Therapy

Withdrawn
Conditions
Kidney Replacement Disorder
First Posted Date
2011-01-13
Last Posted Date
2015-08-20
Lead Sponsor
Klinik für Anästhesiologie
Registration Number
NCT01276392
Locations
🇩🇪

Interdisciplinary Operative Intensive Care Unit, University Hospital Duesseldorf, Duesseldorf, NRW, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.